100
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Identification of ZNF704 as a Novel Oncogene and an Independent Prognostic Marker in Chondrosarcoma

, , , &
Pages 4911-4919 | Published online: 21 Jun 2021

References

  • Amer KM, Munn M, Congiusta D, Abraham JA, Basu Mallick A. Survival and prognosis of chondrosarcoma subtypes: SEER database analysis. J Orthop Res. 2020;38(2):311–319. doi:10.1002/jor.2446331498474
  • Mery B, Espenel S, Guy JB, et al. Biological aspects of chondrosarcoma: leaps and hurdles. Crit Rev Oncol Hematol. 2018;126:32–36. doi:10.1016/j.critrevonc.2018.03.00929759564
  • MacDonald IJ, Lin CY, Kuo SJ, Su CM, Tang CH. An update on current and future treatment options for chondrosarcoma. Expert Rev Anticancer Ther. 2019;19(9):773–786. doi:10.1080/14737140.2019.165973131462102
  • Ye Q, Liu J, Xie K. Zinc finger proteins and regulation of the hallmarks of cancer. Histol Histopathol. 2019;34(10):1097–1109. doi:10.14670/HH-18-12131045237
  • Jen J, Wang YC. Zinc finger proteins in cancer progression. J Biomed Sci. 2016;23(1):53. doi:10.1186/s12929-016-0269-927411336
  • Yang C, Wu J, Liu X, et al. Circadian rhythm is disrupted by ZNF704 in breast carcinogenesis. Cancer Res. 2020;80(19):4114–4128. doi:10.1158/0008-5472.CAN-20-049332651256
  • Chen HQ, Zhao J, Li Y, et al. Gene expression network regulated by DNA methylation and microRNA during microcystin-leucine arginine induced malignant transformation in human hepatocyte L02 cells. Toxicol Lett. 2018;289:42–53. doi:10.1016/j.toxlet.2018.03.00329518473
  • Cheng A, Zhao S, FitzGerald LM, et al. A four-gene transcript score to predict metastatic-lethal progression in men treated for localized prostate cancer: development and validation studies. Prostate. 2019;79(14):1589–1596. doi:10.1002/pros.2388231376183
  • Chen C, Ma Q, Ma X, Liu Z, Liu X. Association of elevated HIF-2alpha levels with low Beclin 1 expression and poor prognosis in patients with chondrosarcoma. Ann Surg Oncol. 2011;18(8):2364–2372. doi:10.1245/s10434-011-1587-521327823
  • Chen C, Zhou H, Zhang X, Liu Z, Ma X. PRMT1 potentiates chondrosarcoma development through activation of YAP activity. Mol Carcinog. 2019;58(12):2193–2206. doi:10.1002/mc.2310831478263
  • Chen C, Tian A, Zhou H, Zhang X, Liu Z, Ma X. Upregulation of miR-211 promotes chondrosarcoma development via targeting tumor suppressor VHL. Onco Targets Ther. 2020;13:2935–2943.32308426
  • Chen C, Tian A, Zhao M, Ma X. Adenoviral delivery of VHL suppresses bone sarcoma cell growth through inhibition of Wnt/beta-catenin signaling. Cancer Gene Ther. 2019;26(3–4):83–93. doi:10.1038/s41417-018-0041-230140042
  • Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–674. doi:10.1016/j.cell.2011.02.01321376230